Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 112 | 1 | 113 | +2 |
| Shares | 64.0M | 8.96K | 67.6M | +3.70M (+5.8%) |
| Value | $879.3M | $63.0K | $478.3M | −$401.0M (−45.6%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (20)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Nicholas Investment Partners, LP | 183,494 | $2.52M |
| Walleye Capital LLC | 149,337 | $2.05M |
| BIT Capital GmbH | 108,624 | $1.49M |
| Campbell & CO Investment Adviser LLC | 96,468 | $1.33M |
| Ratan Capital Management LP | 40,000 | $550.0K |
| Options Solutions, LLC | 33,451 | $460.0K |
| Caption Management, LLC | 31,900 | $438.6K |
| Legato Capital Management LLC | 23,100 | $317.6K |
| Nomura Holdings Inc | 20,512 | $282.0K |
| American International Group, Inc. | 19,236 | $264.5K |
| Virtu Financial LLC | 16,372 | $225.0K |
| ProShare Advisors LLC | 11,733 | $161.3K |
| Oxford Asset Management LLP | 11,689 | $160.7K |
| STRS Ohio | 7,400 | $101.0K |
| Quantbot Technologies LP | 5,700 | $78.4K |
| Metropolitan Life Insurance Co | 2,149 | $29.5K |
| Advisor Group Holdings, Inc. | 281 | $3.86K |
| Federated Hermes, Inc. | 152 | $2.09K |
| NBC Securities, Inc. | 118 | $1.00K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 8 | $110 |
Not filed for Q2 2024 yet (1)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Shell Asset Management Co | 8,965 | $63.0K |